{
  "docId": "019de071-25c2-72af-a047-b47d3e86c276",
  "docSlug": "cf4915d9030a007285d7f2ca06f3bce1",
  "documentTitle": "Graphite Bio | IPO Presentation Deck | 50 slides",
  "authorId": "graphite-bio",
  "authorName": "Graphite Bio",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 24,
  "pageCount": 50,
  "prevPage": 23,
  "nextPage": 25,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "Uses a before-after-bridge framing structure.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-25c2-72af-a047-b47d3e86c276/24",
  "deckHref": "/decks/019de071-25c2-72af-a047-b47d3e86c276",
  "deckJsonHref": "/decks/019de071-25c2-72af-a047-b47d3e86c276.json",
  "deckAnchorHref": "/decks/019de071-25c2-72af-a047-b47d3e86c276#slide-24",
  "components": [
    {
      "bbox": {
        "h": 0.52,
        "w": 0.48,
        "x": 0.46,
        "y": 0.32
      },
      "kind": "image",
      "text": "Grid of patient/team photos",
      "attrs": null,
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e50351c6-14d8-4df4-ba10-e0c11f9280b4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.42,
        "x": 0.04,
        "y": 0.22
      },
      "kind": "list",
      "text": "Among most prevalent monogenic diseases; 100,000 U.S. patients; 30-year reduced life expectancy; Substantial health economic burden; Allo SCT curative, but rarely used (~150 procedures per year in US)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0b88bffc-1ab3-4d10-9514-6b7c1d73a7c2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.48,
        "x": 0.46,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "Correct the Sickle Globin gene to restore normal hemoglobin - so SCD patients can live normal lives",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0dad9edf-d558-467a-95d1-fb6e08b8d6e7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.04,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "1. Rees et al. 2. Piel et al. 3. Song et al. 4. Center for international blood and marrow transplant research.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9f229772-042a-400e-b08a-12a6746bbc60",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.85,
        "x": 0.07,
        "y": 0.04
      },
      "kind": "title",
      "text": "Sickle cell patients desperately in need of curative therapy",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9ba5f506-efd8-4cf1-92cf-0fc14276fdce",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Emotional Appeal",
      "slug": "emotional-appeal",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "eabb8503-1f9c-4a71-a631-b7fe2498e1fd",
      "evidence": "paragraph/paragraph: Correct the Sickle Globin gene to restore normal hemoglobin - so SCD patients can live normal lives",
      "confidence": 0.5
    },
    {
      "name": "Problem-Agitate-Solve (PAS)",
      "slug": "problem-agitate-solve-pas",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "d6772a93-7423-4090-8c94-c9cb8d55de40",
      "evidence": "list/bullet: Among most prevalent monogenic diseases; 100,000 U.S. patients; 30-year reduced life expectancy; Substantial health economic burden; Allo SCT curative, but rarely used (~150 procedures per year in US)",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "before-after-bridge",
      "slug": null,
      "matchId": "0edf667f-cc94-4c6c-922b-8d1117d99ebc",
      "evidence": "Contrasts 'SCD unmet need' with 'Our goal' to bridge the gap.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 25,
      "from": 24,
      "beatId": "47bd7906-8a45-4c8f-8a98-d35865c81ceb",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Problem (Identify pain)",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "The problem statement (p24-25) highlights the need for curative therapy for sickle cell patients.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 25,
      "from": 24,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "4d05b716-3532-4b89-94c2-419df6b1eae9",
      "evidence": "The problem statement (p24-25) highlights the need for curative therapy.",
      "position": 2,
      "objective": "What is the cost of not having a curative therapy for sickle cell disease?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}